相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced Cardiotoxicity
Tarek Magdy et al.
CIRCULATION (2022)
Serum Level of Lactate Dehydrogenase is Associated with Cardiovascular Disease Risk as Determined by the Framingham Risk Score and Arterial Stiffness in a Health-Examined Population in China
Wenfang Zhu et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2022)
Genetics of cancer therapy-associated cardiotoxicity
Yuri Kim et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2022)
Genetics of Anthracycline-Associated Cardiotoxicity
Talal Khalid Al-Otaibi et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
The generation of a lactate-rich environment stimulates cell cycle progression and modulates gene expression on neonatal and hiPSC-derived cardiomyocytes
Jesus Ordono et al.
BIOMATERIALS ADVANCES (2022)
Relationship between lactate dehydrogenase and albuminuria in Chinese hypertensive patients
Xiaoqi Cai et al.
JOURNAL OF CLINICAL HYPERTENSION (2021)
Predicting tissue-specific gene expression from whole blood transcriptome
Mahashweta Basu et al.
SCIENCE ADVANCES (2021)
RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy
Tarek Magdy et al.
CELL STEM CELL (2021)
Serum lactate dehydrogenase activities as systems biomarkers for 48 types of human diseases
Yuling Wu et al.
SCIENTIFIC REPORTS (2021)
Role of Warburg Effect in Cardiovascular Diseases: A Potential Treatment Option
Niken Puspa Kuspriyanti et al.
OPEN CARDIOVASCULAR MEDICINE JOURNAL (2021)
CD36 as a target for metabolic modulation therapy in cardiac disease
Jan F. C. Glatz et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2021)
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
Antonio Abbate et al.
CIRCULATION RESEARCH (2020)
Negligible-Cost and Weekend-Free Chemically Defined Human iPSC Culture
Hui-Hsuan Kuo et al.
STEM CELL REPORTS (2020)
Lactate Dehydrogenase A Governs Cardiac Hypertrophic Growth in Response to Hemodynamic Stress
Chongshan Dai et al.
CELL REPORTS (2020)
Genetics of Anthracycline Cardiomyopathy in Cancer Survivors JACC: CardioOncology State-of-the-Art Review
Smita Bhatia
JACC: CARDIOONCOLOGY (2020)
Cardiotoxicity of Anthracyclines
Daniela Cardinale et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Doxorubicin-induced cardiomyopathy associated with inhibition of autophagic degradation process and defects in mitochondrial respiration
Chowdhury S. Abdullah et al.
SCIENTIFIC REPORTS (2019)
Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset Cardiotoxicity
Elizabeth A. M. Feijen et al.
JAMA ONCOLOGY (2019)
Inhibition of glycolysis disrupts cellular antioxidant defense and sensitizes HepG2 cells to doxorubicin treatment
Agnieszka Korga et al.
FEBS OPEN BIO (2019)
Glucose Metabolism in Cardiac Hypertrophy and Heart Failure
Diem H. Tran et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Fibroblast-specific deletion of IL-1 receptor-1 reduces adverse cardiac remodeling following myocardial infarction
Sumia A. Bageghni et al.
JCI INSIGHT (2019)
Evidence for Genetic Risk Contributing to Long-Term Adverse Treatment Effects in Childhood Cancer Survivors
Maria Monica Gramatges et al.
ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)
NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
Alena Grebe et al.
CIRCULATION RESEARCH (2018)
Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization
Jan F. C. Glatz et al.
JOURNAL OF LIPID RESEARCH (2018)
Metabolic Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes by Inhibition of HIF1 alpha and LDHA
Dongjian Hu et al.
CIRCULATION RESEARCH (2018)
A Review of Interleukin-1 in Heart Disease: Where Do We Stand Today?
Yishay Szekely et al.
CARDIOLOGY AND THERAPY (2018)
Transcriptome of blood cells as a reservoir of cardiovascular biomarkers
Yvan Devaux
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)
Multimodal Regulation of Cardiac Myocyte Proliferation
Xuejun Yuan et al.
CIRCULATION RESEARCH (2017)
Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure
Miranda M. Sung et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2017)
Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity
Paul W. Burridge et al.
NATURE MEDICINE (2016)
Glucose Transporters in Cardiac Metabolism and Hypertrophy
Dan Shao et al.
COMPREHENSIVE PHYSIOLOGY (2016)
Cardiovascular Disease Risk Assessment and Prevention Current Guidelines and Limitations
Peter Alagona et al.
MEDICAL CLINICS OF NORTH AMERICA (2015)
Role of Interleukin-1 in Radiation-Induced Cardiomyopathy
Eleonora Mezzaroma et al.
MOLECULAR MEDICINE (2015)
HTSeq-a Python framework to work with high-throughput sequencing data
Simon Anders et al.
BIOINFORMATICS (2015)
Serum CD121a (Interleukin 1 Receptor, Type I): A Potential Novel Inflammatory Marker for Coronary Heart Disease
Zhengxia Liu et al.
PLOS ONE (2015)
Comparison of Whole Blood and Peripheral Blood Mononuclear Cell Gene Expression for Evaluation of the Perioperative Inflammatory Response in Patients with Advanced Heart Failure
Galyna Bondar et al.
PLOS ONE (2014)
The role of iron in anthracycline cardiotoxicity
Elena Gammella et al.
FRONTIERS IN PHARMACOLOGY (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Matrix Metalloproteinase-9: Many Shades of Function in Cardiovascular Disease
Andriy Yabluchanskiy et al.
PHYSIOLOGY (2013)
Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes
Steven E. Lipshultz et al.
PEDIATRICS (2012)
Role of Genetic Susceptibility in Development of Treatment-Related Adverse Outcomes in Cancer Survivors
Smita Bhatia
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Glucose metabolism and cardiac hypertrophy
Stephen C. Kolwicz et al.
CARDIOVASCULAR RESEARCH (2011)
Recombinant human interleukin-1 receptor antagonist protects mice against acute doxorubicin-induced cardiotoxicity
Jinzhou Zhu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Gene Expression Patterns in Peripheral Blood Correlate with the Extent of Coronary Artery Disease
Peter R. Sinnaeve et al.
PLOS ONE (2009)
Correlation of Peripheral-Blood Gene Expression With the Extent of Coronary Artery Stenosis
James A. Wingrove et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2008)
CD36 expression contributes to age-induced cardiomyopathy in mice
Debby P. Y. Koonen et al.
CIRCULATION (2007)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
Acute overexpression of lactate dehydrogenase-A perturbs β-cell mitochondrial metabolism and insulin secretion
EK Ainscow et al.
DIABETES (2000)
Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.
GM Felker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
